Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-006195
Filing Date
2018-01-09
Accepted
2018-01-08 18:05:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d489256ds3a.htm S-3/A 308660
2 EX-5.1 d489256dex51.htm EX-5.1 16322
3 EX-23.1 d489256dex231.htm EX-23.1 1807
4 GRAPHIC g489256g84s99.jpg GRAPHIC 6071
  Complete submission text file 0001193125-18-006195.txt   336136
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-3/A | Act: 33 | File No.: 333-221402 | Film No.: 18517452
SIC: 2834 Pharmaceutical Preparations